Improved superoxide-generating ability by interferon γ due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene

Blood

Volumn 98, Issue 2, 2001, Pages 436-441

  Ishibashi, Fuminari ^a   Mizukami, Tomoyuki ^a   Kanegasaki, Shiro ^a   Motoda, Lena ^a   Kakinuma, Ryota ^a   Endo, Fumio ^a   Nunoi, Hiroyuki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYBB GENE; EXON; GENE; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; MALE; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL; PROMYELOCYTE; RNA SPLICING; SILENT GENE;

EID: 0035880240     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.2.436     Document Type: Article

References (39)

1. Roos D, de Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 1996;87:1663-1681.
2. Parkos CA, Allen RA, Cochrane CG, Jesaitis AJ. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest. 1987;80:732-742.
3. Nunoi H, Rotrosen D, Gallin JI, Malech HL. Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science. 1988;242:1298-1301.
4. Rae J, Newburger PE, Dinauer MC, et al. X-linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Am J Hum Genet. 1998;62:1320-1331.
5. Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki S. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet. 2000;106:473-481.
6. Nathan CF, Prendergast TJ, Wiebe ME, et al. Activation of human macrophages: comparison of other cytokines with interferon-gamma. J Exp Med. 1984;160:600-605.
7. Berton G, Zeni L, Cassatella MA, Rossi F. Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun. 1986;138:1276-1282.
8. Ezekowitz RAB, Orkin SH, Newburger PE. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J Clin Invest. 1987;80:1009-1016.
9. Ezekowitz RAB, Dinauer MC, Jaffe HS, Orkin SH, Newburger PE. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med. 1988;319:146-151.
10. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324:509-516.
11. Weening RS, Leitz GJ, Seger RA. Recombinant human interferon-gamma in patients with chronic granulomatous disease-European follow up study. Eur J Pediatr. 1995;154:295-298.
12. Condino-Neto A, Newburger PE. Interferongamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood. 2000;95:3548-3554.
13. McPhail LC, Snyderman R. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli: evidence that the same oxidase is activated by different transductional mechanisms. J Clin Invest. 1983;72:192-200.
14. Hui YF, Chan SY, Lau YL. Identification of mutations in seven Chinese patients with X-linked chronic granulomatous disease. Blood. 1996;88:4021-4028.
15. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178:89-97.
16. 558 of human neutrophils: immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease, and their carrier mothers. Blood. 1987;69:1404-1408.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
18. Dinauer MC, Curnutte JT, Rosen H, Orkin SH. A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease. J Clin Invest. 1989;84:2012-2016.
19. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987;15:7155-7174.
20. Watakabe A, Tanaka K, Shimura Y. The role of exon sequences in splice site selection. Genes Dev. 1993;7:407-418.
21. Tolstrup AB, Bejder A, Fleckner J, Justesen J. Transcriptional regulation of the interferon-γ-inducible tryptophanyl-tRNA synthetase includes alternative splicing. J Biol Chem. 1995;270:397-403.
22. Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA tissue-specific regulation and induction by cytokines. J Biol Chem. 1996;271:27184-27187.
23. He X, Le J. Alternative splicing of HLA class I transcripts induced by IFN-γ and TNF in fibroblasts: release of soluble HLA class I heavy chain and an associate protein. Cell Immunol. 1995;162:159-168.
24. Ge H, Manley JL. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early premRNA in vitro. Cell. 1990;62:25-34.
25. Mayeda A, Krainer AR. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell. 1992;68:365-375.
26. Mayeda A, Badolato J, Kobayashi R, Zhang MQ, Gardiner EM, Krainer AR. Purification and characterization of human RNPS1: a general activator of pre-mRNA splicing. EMBO J. 1999;18:4560-4570.
27. Ramchatesingh J, Zahler AM, Neugebauer KM, Roth MB, Cooper TA. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol Cell Biol. 1995;15:4898-4907.
28. Caputi M, Mayeda A, Krainer AR, Zahler AM. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 1999;18:4060-4067.
29. Ezekowitz RAB, Sieff CA, Dinauer MC, Nathan DG, Orkin SH, Newburger PE. Restoration of phagocyte function by interferon-γ in X-linked chronic granulomatous disease occurs at the level of a progenitor cell: Blood. 1990;76:2443-2448.
30. + hematopoietic progenitor cells. Blood. 1992;79:2628-2635.
31. Shiohara M, Koike K, Nakahata T. Synergism of interferon-γ and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture. Blood. 1993;81:1435-1441.
32. Weening RS, de Klein A, de Boer M, Roos D. Effect of interferon-γ, in vitro and in vivo, on mRNA levels of phagocyte oxidase components. J Leukoc Biol. 1996;60:716-720.
33. 558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system. Arch Biochem Biophys. 1998;360:158-164.
34. Newburger PE, Ezekowitz RAB, Whitney C, Wright J, Orkin SH. Induction of phagocyte cytochrome b heavy chain gene expression by interferon-γ. Proc Natl Acad Sci U S A. 1988;85:5215-5219.
35. Cassatella MA, Bazzoni F, Flynn RM, Dusi S, Trinchieri G, Rossi F. Molecular basis of interferon-γ and lipopolysaccharide enhancement of phagocyte respiratory burst capability: studies on the gene expression of several NADPH oxidase components. J Biol Chem. 1990;265:20241-20246.
36. Amezaga MA, Bazzoni F, Sorio C, Rossi F, Cassatella MA. Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon-γ-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (Fc γ R-I) in human polymorphonuclear leukocytes. Blood. 1992;79:735-744.
37. Ahlin A, Elinder G, Palmblad J. Dose-dependent enhancements by interferon-γ on functional responses of neutrophils from chronic granulomatous disease patients. Blood. 1997;89:3396-3401.
38. Eklund EA, Luo W, Skalnik DG. Characterization of three promoter elements and cognate DNA binding protein(s) necessary for IFN-γ induction of gp91-phox transcription. J Immunol. 1998;157:2418-2429.
39. 558 identification of two juxtaposed extracellular domains. J Biol Chem. 2001;276:2053-2061.